X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (86) 86
male (60) 60
female (55) 55
middle aged (52) 52
gastroenterology & hepatology (51) 51
index medicus (45) 45
adult (38) 38
aged (37) 37
life sciences (28) 28
cirrhosis (23) 23
prospective studies (18) 18
france (17) 17
liver (17) 17
liver cirrhosis - complications (16) 16
prognosis (15) 15
treatment outcome (15) 15
aged, 80 and over (14) 14
liver cirrhosis (14) 14
care and treatment (13) 13
hepatitis c (13) 13
human health and pathology (13) 13
cancer (12) 12
drug therapy, combination (12) 12
health aspects (12) 12
mortality (12) 12
recurrence (12) 12
risk factors (12) 12
abridged index medicus (11) 11
hepatitis (11) 11
hepatitis c virus (11) 11
analysis (10) 10
france - epidemiology (10) 10
gastroenterology and hepatology (10) 10
immunology (10) 10
risk (10) 10
infection (9) 9
liver cirrhosis - mortality (9) 9
retrospective studies (9) 9
virus-infection (9) 9
antiviral agents - therapeutic use (8) 8
follow-up studies (8) 8
liver cancer (8) 8
management (8) 8
medicine, general & internal (8) 8
survival (8) 8
therapy (8) 8
time factors (8) 8
antiviral agents (7) 7
biopsy (7) 7
complications (7) 7
drug therapy (7) 7
hépatology and gastroenterology (7) 7
infections (7) 7
oncology (7) 7
patients (7) 7
portal hypertension (7) 7
portal-hypertension (7) 7
ribavirin (7) 7
severity of illness index (7) 7
surgery (7) 7
bacterial infections (6) 6
diagnosis (6) 6
digestive system diseases (6) 6
fibrosis (6) 6
gastroenterology (6) 6
gastrointestinal hemorrhage - etiology (6) 6
gastrointestinal hemorrhage - therapy (6) 6
hepatitis c - drug therapy (6) 6
hepatitis c, chronic - complications (6) 6
liver cirrhosis - virology (6) 6
liver transplantation (6) 6
medicine & public health (6) 6
multivariate analysis (6) 6
octreotide (6) 6
patient outcomes (6) 6
predictive value of tests (6) 6
survival analysis (6) 6
transplantation (6) 6
[sdv.mhep.heg]life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (5) 5
acute disease (5) 5
adolescent (5) 5
anrs co12 cirvir (5) 5
association (5) 5
cohort studies (5) 5
double-blind method (5) 5
epidemiology (5) 5
esophageal and gastric varices - complications (5) 5
esophageal and gastric varices - drug therapy (5) 5
esophageal-varices (5) 5
gastrointestinal hemorrhage - drug therapy (5) 5
hemorrhage (5) 5
hepatocellular-carcinoma (5) 5
hepatology (5) 5
hepatoma (5) 5
hypertension (5) 5
incidence (5) 5
interferon (5) 5
kaplan-meier estimate (5) 5
liver neoplasms - mortality (5) 5
natural-history (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 111, Issue 1, pp. 38 - 44
Journal Article
Revue de l'Infirmiere, ISSN 1293-8505, 2015, Issue 207, pp. 16 - 18
Journal Article
Revue de l'infirmiere, ISSN 1293-8505, 01/2015, Issue 207, p. 16
All chronic liver diseases, whatever their causes, can lead to cirrhosis, when they evolve untreated for more than 10 to 20 years. The diagnosis of cirrhosis... 
Liver Cirrhosis - epidemiology | Ascites - etiology | France - epidemiology | Gastrointestinal Hemorrhage - etiology | Liver Cirrhosis - complications | Bacterial Infections - etiology | Humans | Esophageal and Gastric Varices - complications | Hepatic Encephalopathy - etiology | Liver Cirrhosis - therapy
Journal Article
Journal Article
by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2171 - 2181
Journal Article
Hepatology, ISSN 0270-9139, 09/2015, Volume 62, Issue 3, pp. 737 - 750
Journal Article
Revue du Praticien, ISSN 0035-2640, 05/2011, Volume 61, Issue 5, pp. 687 - 697
Journal Article
La Revue du praticien, ISSN 0035-2640, 05/2011, Volume 61, Issue 5, p. 687
Journal Article
Liver International, ISSN 1478-3223, 09/2017, Volume 37, Issue 9, pp. 1314 - 1324
Journal Article
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 08/2019, Volume 10, p. 2014
Journal Article
Hepatology, ISSN 0270-9139, 10/2016, Volume 64, Issue 4, pp. 1136 - 1147
Journal Article